Trials / Sponsors / MultiVir, Inc.
MultiVir, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Live Metastatic Solid Tumor Cancer, Recurrent Head and Neck Cancer | Phase 1 / Phase 2 | 2018-11-20 |
| Unknown | Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. Solid Tumor, Lymphoma | Phase 2 | 2018-10-01 |